Medical devices, healthcare technology and the business of care
510(k) clearance · K262130

ATTUNE Revision Knee System

Depuy Orthopaedics, Inc. · Decision date Sep 4, 2026

MEDTECHLEDGER EXPLANATIONK262130

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on September 4, 2026 for the ATTUNE Revision Knee System, a traditional 510(k) submitted by DePuy Orthopaedics, Inc. and received June 24, 2026 under K262130. The device is classified under 21 CFR 888.3560 as a knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis, Class II, with product codes JWH and MBH; the review specialty is orthopedic.

The 510(k) summary frames the submission around manufacturing changes rather than a new device: ram extrusion as an alternative raw material consolidation method and splitting the sterilization dose into two steps, crosslinking of raw material and terminal sterilization of the finished good. The applicant states these do not affect intended use, performance, safety, effectiveness, biocompatibility, standards compliance or labeling set by the predicate. The summary does not identify the predicate device by number, so that relationship remains unverified here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 4, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262130
Regulatory pathway
510(k) premarket notification
Product code
JWH
Decision code
SESE
Decision date
Sep 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer.

Product code
JWH
FDA device class
2

FDA decision timeline

  1. K262130 received

    Application receipt date recorded by FDA.

  2. K262130 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code JWH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Depuy Orthopaedics, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Warsaw, IN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records